--Invitation Homes Keeps Quarterly Dividend of $0.28 per Share, Payable April 19 to Investors of Record on March 28-March 2024-www.financetom.com

--Invitation Homes Keeps Quarterly Dividend of $0.28 per Share, Payable April 19 to Investors of Record on March 28

News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities

--Invitation Homes Keeps Quarterly Dividend of $0.28 per Share, Payable April 19 to Investors of Record on March 28

Mar 15, 2024 6:44 AM

09:21 AM EDT, 03/15/2024 (MT Newswires) --

Price: 35.69, Change: +0.82, Percent Change: +2.35

Previous page： The US sanctions 10 Hamas members and its financial network over the surprise Israel attack Next page： Mahindra, Volvo among corporations pushing for fossil fuel exit at COP28

Comments

Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.

Show More Comments

Related Articles >

The US sanctions 10 Hamas members and its financial network over the surprise Israel attack

Oct 18, 2023

The sanctions are financial penalties meant to block access to funds held in the U.S. and to prevent the people and entities from doing business with American people and firms.

Mahindra, Volvo among corporations pushing for fossil fuel exit at COP28

Oct 23, 2023

Companies are increasingly committing to their own timelines for reducing their emissions, but many acknowledge that their ability to slow planet-warming CO2 emissions is contingent on faster action from governments.

Pakistan's national carrier resorts to flight cancellation owing to non-payment of dues

Oct 23, 2023

The airline, which was once considered the pride of Pakistan and was the first international airline to be given access to fly to Beijing, is said to be suffering millions in losses on a daily basis.

Pfizer’s $43 billion purchase of Seagen gets green light from EU antitrust

Oct 20, 2023

Pfizer announced the deal in March, its largest purchase in a string of recent acquisitions thanks to a once-in-a-lifetime cash windfall from its COVID-19 vaccine and treatment.